OOIR: Observatory of International Research

Papers

(The H4-Index of Molecular Oncology is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Genomic and immune characteristics of HER2‐mutated non‐small‐cell lung cancer and response to immune checkpoint inhibitor‐based therapy	195
From the creation of the European research area in 2000 to a Mission on cancer in Europe in 2021‐lessons learned and implications	95
	85
Comparing single‐target and multitarget approaches for postoperative circulating tumour DNA detection in stage II–III colorectal cancer patients	82
An arms‐race against resistance: leukemic stem cells and lineage plasticity	79
The synthetic oleanane triterpenoid CDDO‐2P‐Im binds GRP78/BiP to induce unfolded protein response‐mediated apoptosis in myeloma	74
Issue Information	65
Whole‐genome sequencing of cell‐free DNA reveals DNA of tumor origin in plasma from patients with colorectal adenomas	62
Stochastic variation in the FOXM1 transcription program mediates replication stress tolerance	61
Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study	58
Exploration of heterogeneity and recurrence signatures in hepatocellular carcinoma	57
Correction to “SPT6 recruits SND1 to co‐activate human telomerase reverse transcriptase to promote colon cancer progression”	50
Correction to “Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition”	49
The polyamine transporter ATP13A3 mediates difluoromethylornithine‐induced polyamine uptake in neuroblastoma	49
Cytokine‐centered strategies to boost cancer immunotherapy	48
Copy number variations contribute to malignant tumor development in children with serious birth defects	48
Tonabersat enhances temozolomide‐mediated cytotoxicity in glioblastoma by disrupting intercellular connectivity through connexin 43 inhibition	47
Consensus molecular subtyping of colorectal carcinoma brain metastases reveals a metabolic signature associated with poor patient survival	43
Early assessment of circulating tumor DNA after curative‐intent resection predicts tumor recurrence in early‐stage and locally advanced non‐small‐cell lung cancer	40
Pogo transposons provide tools to restrict cancer growth	40
Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration‐resistant prostate cancer undergoing first‐line abiraterone acetate and pred	37
FBXL16 promotes cell growth and drug resistance in lung adenocarcinomas with KRAS mutation by stabilizing IRS1 and upregulating IRS1/AKT signaling	35
Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti‐CD73/anti‐PD‐L1 immunotherapy in arm A of the NSGO	34
Ovarian cancer relies on the PDGFRβ–fibronectin axis for tumorsphere formation and metastatic spread	34
Targeting mitochondrial respiration and the BCL2 family in high‐grade MYC‐associated B‐cell lymphoma	33

Molecular and functional profiling unravels targetable vulnerabilities in colorectal cancer	33
A new function for the serine protease HtrA2 in controlling radiation‐induced senescence in cancer cells	32
Androgen receptor‐mediated transcriptional repression targets cell plasticity in prostate cancer	32
Postbiotics of Lacticaseibacillus paracaseiCECT 9610 and Lactiplantibacillus plantarumCECT 9608 attenuates store‐operated calcium entry and FAK phosphory	30
Issue Information	30
Navigating the current landscape of scientific publishing – the Molecular Oncology perspective	30